Look, anyone selling short term to protect against a small downturn due to short covering and governmental confusion is just risking not getting back in to gain monstrous returns from ISIS technology and upcoming partnership compensation. This company is probably the biggest blockbuster on the immediate horizon. There should be a couple of positive announcements coming out about ISIS every week for the next month and then regularly scheduled partnership payments happening. ISIS is on the verge of supplying great drugs to the world for the best treatment of lots of diseases.
Remember that 92% of ISIS shares are owned by institutions that know the true potential. They would love to get their hands on your shares!